U.S. companies seized the opportunity to develop Covid-19 vaccine

The Covid-19 pandemic has brought the need to develop new medicaments.
The pharmaceutical industry has soon begun to develop and test vaccines and drugs against the new virus.

Moderna stocks expand to record highs

During last year, Moderna stocks surpassed wider market and experienced record growth of 509% (to the date of 26th August 2021). The value exceeded total returns of the S&P 500 index reaching 28% (to the date of 26th August 2021).

Delta mutation will cool down the optimism of economic recovery

Macroeconomic forecasts of major European and global institutions have yet to reflect the spread of the Delta variant of SARS-CoV-2.